Skip to main content
By kristalamb
Posted date: December 01, 2017

Dr. Carpentier is the co-director of Diabetes Action Canada Training and Mentoring Goal Group and the recipient of the GSK Research Chair in Diabetes of Université de Sherbrooke, professor and endocrinologist-lipidologist in the Departments of Medicine, Faculty of Medicine at the Université de Sherbrooke. He is also the director of the university’s Centre de recherche sur le diabète, l’obésité et les complications cardiovasculaires and the director of the Province of Quebec Research Network on Cardiometabolic Health, Diabetes and Obesity. His research interests include: 1) the role of postprandial fatty acid metabolism in the development of type 2 diabetes and cardiovascular diseases; 2) the investigation of brown adipose tissue metabolism in humans; and 3) the anti-diabetic mechanisms of bariatric surgery. Dr. Carpentier has published more than 124 peer-reviewed manuscript publications. He is the recipient for multiple awards, including the 2011 Diabetes Young Investigator Award of the Canadian Society of Endocrinology and Metabolism, the CDA/CIHR Young Investigator Award in 2012 and the Canadian Lipoprotein Conference Physician-Scientist Award in 2014. He has been elected Fellow of the Canadian Academy of Health Sciences (FCAHS, 2015).

 


Articles

CIHR and JDRF join forces to focus on the needs of individuals with Type-1 Diabetes

How I went from WOW to OH, to OMG to RESPECT on my first meeting with Diabetes Action Canada